Shares of Humana Inc. HUM slipped 4.41% to $253.77 Friday, on what proved to be an all-around grim trading session for the ...

Currently, Humana has a poor Growth Score of F, a grade with the same score on the momentum front. However, the stock was allocated a grade of A on the value side, putting it in the top 20% for ...

Humana’s stock tacked on 1.2% in morning trading ... policy not to comment on rumors our speculation. Hynes said her analysis for Cigna buying Humana assumes an all-cash deal valued at roughly ...

HUMANA INC (HUM) is a large-cap growth stock in the Healthcare Facilities industry. The rating using this strategy is 60% based on the firm’s underlying fundamentals and the stock’s valuation.

Is Humana a buy or sell going into earnings? Read our full analysis here ... Luckily, we’ve found one, a low-priced stock that is gushing free cash flow AND buying back shares.

For the most current analysis and real-time insights, including Humana's Fair Value estimate ... HUM appears on our undervalued or overvalued stock lists. These tools provide a clearer picture ...

Humana (HUM) stock is plunging in Wednesday's session after the health benefits company announced preliminary 2025 Medicare Advantage (MA) Star Ratings data provided by the Centers for Medicare ...

and Toyota Motor Corp. (TM), as well as a micro-cap stock Better Choice Company Inc. (BTTR). LOUISVILLE, Ky., March 05, 2025--Humana Inc. (the "company") (NYSE: HUM) announced today the completion ...

JPMorgan Chase & Co. dropped their price target on Humana from $257.00 to $256.00 and set a “neutral” rating on the stock in a research note on Tuesday, February 18th. Cantor Fitzgerald reiter ...

The stock's fall snapped a two-day winning streak.

For the most current analysis and real-time insights, including Humana’s Fair Value estimate and comprehensive ... You can also see if HUM appears on our undervalued or overvalued stock lists. These ...